Stereotaxis, Inc. (STXS), Monday announced it has received U.S. Food and Drug Administration 510(k) clearance for its MAGiC Sweep catheter, the first ever robotically navigated high-density electrophysiology mapping catheter to diagnose and treat complex arrhythmia patients.
The company added that the catheter reflects its commitment to significant innovations that advance robotics in electrophysiology and across endovascular interventions.
In the pre-market hours, STXS is moving up 11.40 percent, to $2.5 on the New York Stock Exchange American.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.